The purpose of this requirement is to provide medical countermeasures (mcms), such as vaccines and adjuvants, for pandemic preparedness and response or as required in response to a HHS designated

Ended Awarded Last action

Contract number
75A50122F61001
Awardee
Awarding agency
Obligated
$1,904,213

Award facts

Contract value 100% obligated
$1,904,213.20 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Holly Springs, NC, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 · To DE-obligation & closeout task order. -$280
Other Administrative Action P00002 $0
Modification $1,904,493
Other Administrative Action P00001 $0

About this award

This federal contract award to Seqirus Inc., a division of global biotechnology company CSL Seqirus, has a ceiling value of $1,904,213.20. The purpose of the contract is to provide medical countermeasures (MCMs), such as vaccines and adjuvants, for pandemic preparedness and response as required by the Department of Health and Human Services (HHS).

Seqirus operates a manufacturing facility in Holly Springs, North Carolina and is a leading provider of MCMs to the U.S. federal government. The contract is a Delivery Order issued under Seqirus' $13.4 billion Indefinite Delivery Contract (IDC) with the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). This flexible contracting vehicle allows ASPR to rapidly procure a wide range of MCMs and related services from Seqirus to support pandemic preparedness initiatives. The contract does not have a set-aside designation.

Subawards

Subcontractor Amount Awarded
Amplifybio LLC INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT… $53,760

Quick answers

Who was awarded contract 75A50122F61001?

75A50122F61001 was awarded to Seqirus Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on February 22, 2022.

How much is contract 75A50122F61001 worth?

The government has obligated $1,904,213 on 75A50122F61001.

Is contract 75A50122F61001 an order under another contract?

Yes. 75A50122F61001 is a delivery order under 75A50122D00004, an indefinite delivery contract.

Was contract 75A50122F61001 competed?

The extent of competition for 75A50122F61001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award